Biotech News 15 May 2024 Nanotechnology vaccines could protect against unknown coronaviruses Researchers say nanotechnology could help develop vaccines rapidly in case of a new pandemic. Scientists have developed a new vaccine… Pantitra
Biotech News 03 May 2024 Transformative Technologies in Vaccine Manufacturing New technologies will be essential to allow for rapid, safe and large-scale production of vaccines, especially in developing countries. Vaccines… Pantitra
Biotech News 29 Apr 2024 With whooping cough cases on the rise, do you need a booster vaccine? Cases of pertussis are particularly dangerous for babies, experts warn — here's what to know for all ages As whooping… Pantitra
Biotech News 19 Apr 2024 Whooping Cough Cases Rise Across Europe, Asia And Parts Of U.S. Whooping cough outbreaks are expanding across Europe, Asia and parts of the United States, including Northern California. Since December of last… Pantitra
BioNet News 05 Apr 2024 BioNet aP on its way to support Thailand’s Universal Coverage Scheme, managed by NHSO The shipment is underway. Our acellular pertussis vaccines (aP) are officially on the move, heading to support the Universal Coverage… Pantitra
Biotech News 02 Apr 2024 Australia’s first purpose-built facility to deliver human challenge trials launches in Melbourne The new facility will accelerate the development of novel medicines and vaccines. Australia’s first clinical trial facility specifically commissioned to… Pantitra
Biotech News 20 Mar 2024 New DNA Origami Platform, DoriVac, Opens New Path for Designer Cancer Vaccine Development The central ingredient of therapeutic cancer vaccines is antigens, which are preferentially produced or newly produced (neoantigens) by tumor cells… Pantitra
Biotech News 11 Mar 2024 MIT scientists use a new type of nanoparticle to make vaccines more powerful Study shows metal-organic particles can both deliver vaccines and act as an adjuvant to generate a strong immune response at… Pantitra
Biotech News 18 Jan 2024 Accelerating Recombinant Protein Vaccine Development WuXi Vaccines describes technologies that hasten the progress from vaccine discovery to commercialization Recombinant protein vaccines, which are obtained by… Pantitra
BioNet News 12 Jan 2024 Effective and safe transfer of maternal antibodies persisting two months postpartum following maternal immunization with different doses of recombinant pertussis-containing vaccines Recombinant acellular pertussis (ap) vaccines containing genetically inactivated pertussis toxin (PTgen) and filamentous hemagglutinin (FHA) with or without tetanus (TT)… Pantitra
